vimarsana.com
Home
Live Updates
First Gene Therapy for Hemophilia B, CSLs HEMGENIX®, Approved by the European Commission : comparemela.com
First Gene Therapy for Hemophilia B, CSL's HEMGENIX®, Approved by the European Commission
/PRNewswire/ -- Global biotechnology leader CSL (ASX: CSL) today announced that the European Commission has granted conditional marketing authorization (CMA)...
Related Keywords
Germany ,
Norway ,
Australia ,
Iceland ,
Liechtenstein ,
United Kingdom ,
Frankfurt ,
Brandenburg ,
Stephanie Fuchs ,
Wolfgang Miesbach ,
Greg Healy ,
Kim Odonohue ,
Lutz Bonacker ,
Jimmy Baker ,
Care Center ,
Twitter ,
European Commission ,
Regulatory Agency ,
European Union ,
University Hospital Of Frankfurt ,
European Medicines Agency ,
Committee For Medicinal Products Human Use ,
Head Of Research Development ,
European Economic Area ,
Bill Mezzanotte ,
Chief Medical Officer ,
Medicinal Products ,
Human Use ,
Professor Wolfgang Miesbach ,
Coagulation Disorders ,
Comprehensive Care Center ,
University Hospital ,
Senior Vice President ,
General Manager ,
Commercial Operations Europe ,
Drug Administration ,
Annual Bleeding Rate ,
First Gene ,
Annual Congress ,
Latest Clinical Trial Results Session ,
Csl ,
comparemela.com © 2020. All Rights Reserved.